| Value | ₹0.01 Cr |
|---|---|
| Execution period | 3 years from the vesting date |
BSE filing, NSE: ICRA. Summary written from the filing by ALFA Finder's alert engine.
ICRA Ltd: key numbers
- Share price
- ₹4,463.50
- Market cap
- ₹4,308 Cr
- Revenue (annual)
- ₹599.5 Cr
- Net profit (annual)
- ₹181.5 Cr
- P/E (TTM)
- 22.1×Sector 19.7×
- Promoter holding
- 51.87%+0.00% QoQ
- FII holding
- 8.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from ICRA Ltd
All →ICRA Board Meeting Date
ICRA Limited has scheduled a board meeting on October 29, 2026, to consider and approve the company's unaudited standalone and consolidated financial results.
ICRA Other Announcement
ICRA Ltd has filed its quarterly shareholding pattern as mandated by SEBI regulations. This routine disclosure reports current promoter and public shareholding positions.
ICRA Management Change
ICRA appointed Mr. Ritesh Gupta as Executive Vice President & Chief Business Officer-Designate, effective October 12, 2026. He succeeds Mr. L. Shivakumar, who retires December 31, 2026.
ICRA Other Announcement
The Adivam Family Trust, a connected person, sold 500 equity shares of ICRA Ltd in a market sale transaction. The total value of the sale is Rs.0.24 Crore.
- Value
- ₹0.24 Cr
ICRA Employee Stock Options
KMP Venkatesh Viswanathan acquired 206 equity shares of ICRA Ltd valued at ₹0.10 Crore through an ESOP exercise. The transaction occurred on August 31, 2026.
- Value
- ₹0.10 Cr
ICRA Employee Stock Options
KMP Amit Gupta acquired 346 shares of ICRA Ltd valued at approximately Rs. 0.17 Crore through an ESOP exercise. This insider trading disclosure reports the transaction.
- Value
- ₹0.17 Cr
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date